Gilead will close Philadelphia, Seattle offices as part of job reductions

Au­rinia Phar­ma­ceu­ti­cals said it will start ex­plor­ing strate­gic al­ter­na­tives, in­clud­ing a po­ten­tial sale. The an­nounce­ment fol­lows calls by one of its ma­jor share­hold­ers, MKT Cap­i­tal.

Spring­Works Ther­a­peu­tics won FDA ap­proval for its desmoid tu­mor treat­ment Og­siveo on Mon­day, fol­low­ing a three-month reg­u­la­to­ry hic­cup. Desmoid tu­mors are rare but lo­cal­ly ag­gres­sive